Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case–control study

Aims Antiplatelet drugs are often discontinued early after ischaemic stroke, either because of poor compliance, complications or withdrawal of care. It is unclear whether this places patients at increased risk of recurrence. We explored the association between cardiovascular event rate and persisten...

Ausführliche Beschreibung